Editorial: Are inflammatory biomarkers following bioresorbable scaffold or drug-eluting stent implantation directly linked to outcomes?

Cardiovasc Revasc Med. 2024 Apr:61:82-84. doi: 10.1016/j.carrev.2024.01.010. Epub 2024 Jan 15.

Authors

Patrick W Serruys¹, Kotaro Miyashita², Scot Garg³, Yoshinobu Onuma²

Affiliations

¹ School of Medicine, University of Galway (UOG), Galway, Ireland. Electronic address: patrick.serruys@universityofgalway.ie.
² School of Medicine, University of Galway (UOG), Galway, Ireland.
³ Department of Cardiology, Royal Blackburn Hospital, Blackburn, United Kingdom.

PMID: 38280826
DOI: 10.1016/j.carrev.2024.01.010

No abstract available

Publication types

Editorial

MeSH terms

Absorbable Implants
Biomarkers
Coronary Artery Disease* / diagnostic imaging
Coronary Artery Disease* / surgery
Drug-Eluting Stents*
Everolimus
Humans

Substances

Everolimus
Biomarkers